Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit
- 30 October 2009
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (1) , 73-80
Abstract
Glycopeptides and linezolid are the most widely used antibiotics to treat infections by methicillin-resistant Staphylococcus spp. We report the presence of various isolates of methicillin-resistant S. hominis subsp. hominis with resistance to linezolid and reduced susceptibility to glycopeptides. We studied ten blood culture isolates of S. hominis subsp. hominis from nine patients admitted to our hospital. Etest was used to study susceptibility to antibiotics commonly prescribed against staphylococci. Domain V region of the 23S rRNA gene was amplified and sequenced to detect possible mutations that confer resistance to linezolid. Pulsed-field gel electrophoresis (PFGE) was used for the clonality study of isolates. All isolates were resistant to oxacillin, gentamicin, levofloxacin, cotrimoxazole, and linezolid, and susceptible to tigecycline and daptomycin. Nine of the isolates were resistant to erythromycin and clindamycin, and showed heterogeneous resistance to glycopeptides. C2190T, G2603T, and G2474T mutations were detected in domain V of the 23S rRNA gene. PFGE showed the presence of two different clones. This report alerts to the possible appearance of clinical strains of methicillin-resistant staphylococci with intermediate resistance to glycopeptides, resistance to linezolid, and multiple resistance to other second-line antibiotics.Keywords
This publication has 30 references indexed in Scilit:
- Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA geneInternational Journal of Antimicrobial Agents, 2009
- First Report of cfr -Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United StatesAntimicrobial Agents and Chemotherapy, 2008
- An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unitJournal of Antimicrobial Chemotherapy, 2008
- Sequential Linezolid-Resistant Staphylococcus epidermidis Isolates with G2576T MutationJournal of Clinical Microbiology, 2007
- Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitalsClinical Microbiology and Infection, 2007
- A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA)Annals of Clinical Microbiology and Antimicrobials, 2007
- Resistance in the intensive care unit: Whose problem is it and how can intensivists help?*Critical Care Medicine, 2007
- Epidemiological Profile of Linezolid‐Resistant Coagulase‐Negative StaphylococciClinical Infectious Diseases, 2006
- Consolidación de un clon multirresistente de Staphylococcus aureus no relacionado con el clon Ibérico en un hospital de MallorcaEnfermedades Infecciosas y Microbiología Clínica, 2005
- Molecular Detection of Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis by Use of 5′ Nuclease Real-Time PCR Compared to a Modified Classical ApproachJournal of Clinical Microbiology, 2004